Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Side effects of ranitidine.

T Vial1, C Goubier, A Bergeret

  • 1Service de Pharmaco-Toxicovigilance, Hôpital Edouard Herriot, Lyon, France.

Drug Safety
|March 1, 1991
PubMed
Summary

Ranitidine, a histamine H2-receptor antagonist, is generally well-tolerated for gastroduodenal diseases. While side effects like headaches and mild GI issues occur, serious adverse events are rare, supporting its established safety profile.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SBR operational strategies for directing mixed microbial cultures toward levulinic acid production using hexoses.

Frontiers in bioengineering and biotechnology·2026
Same author

Histological and microbiological evaluation of surgical wound closure in mouse skin with cyanoacrylate (Histoacryl®) in comparison to poliglecaprone (Monocryl®) traditional suture.

Veterinary and animal science·2021
Same author

[Kinematic gait pattern with silicone ankle-foot ortesis in patients with drop foot].

Acta ortopedica mexicana·2021
Same author

Strategy for biological co-production of levulinic acid and polyhydroxyalkanoates by using mixed microbial cultures fed with synthetic hemicellulose hydrolysate.

Bioresource technology·2020
Same author

Indicators of long-term return to work after severe traumatic brain injury: A cohort study.

Annals of physical and rehabilitation medicine·2018
Same author

Road casualties in work-related and private contexts: occupational medical impact. Results from the ESPARR cohort.

Work (Reading, Mass.)·2018

Area of Science:

  • Pharmacology and Therapeutics
  • Gastroenterology
  • Drug Safety and Pharmacovigilance

Background:

  • Ranitidine, a histamine H2-receptor antagonist, has been widely used since 1981 for treating gastroduodenal diseases.
  • Extensive clinical experience has accumulated regarding its safety profile.
  • Numerous ranitidine-associated side effects have been reported, though infrequently.

Purpose of the Study:

  • To critically assess the evidence supporting a causal relationship between ranitidine and reported side effects.
  • To evaluate the overall safety and tolerability of ranitidine based on available data.

Main Methods:

  • Review of accumulated clinical experience and published literature on ranitidine safety.
  • Analysis of reported side effects, including general, cardiovascular, hepatic, neuropsychiatric, and hematological complications.

Related Experiment Videos

  • Comparison of incidence rates with placebo and assessment of potential causal links.

    • Main Results:

    • Ranitidine is generally well-tolerated, with general side effects (<2%) similar to placebo.
    • Common complaints include headaches, tiredness, dizziness, and mild gastrointestinal disturbances, rarely leading to treatment discontinuation.
    • Cardiovascular and hepatic side effects are extremely rare; neuropsychiatric and hematological complications are also infrequent and often difficult to definitively link to ranitidine.

    Conclusions:

    • Ranitidine demonstrates a favorable safety profile with a low incidence of significant adverse events.
    • The evidence for a strong causal link between ranitidine and most reported severe side effects is weak.
    • Ranitidine remains a well-tolerated option for gastroduodenal disease treatment.